Home β€Ί Stock analysis β€Ί HAO

Haoxi Health Technology (HAO) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

HAO rises 1.4% to $2.19. Closed at $2.19, +1.39% vs the prior close of $2.16. Day range $2.10–$2.27, opened at $2.27.

Last close$2.19+1.39%
Day range2.10–2.27
Open2.27
Volume31.50K
52-week range2.10–4,352.00
Avg volume (20d)111.96K

HAO daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 β€” HAO rises 1.4% to $2.19
Oct 14, 2026 β€” HAO slides 4.8% to $2.16, a 52-week low
Oct 13, 2026 β€” HAO slides 7.0% to $2.27, a 52-week low
Oct 12, 2026 β€” HAO rises 1.7% to $2.44
Oct 9, 2026 β€” HAO slides 4.0% to $2.40, a 52-week low
Oct 8, 2026 β€” HAO slides 3.8% to $2.50
Oct 7, 2026 β€” HAO jumps 7.4% to $2.60
Oct 6, 2026 β€” HAO slides 8.2% to $2.42, a 52-week low, 9 down days in a row
Oct 5, 2026 β€” HAO dips 2.4% to $2.63, a 52-week low, 8 down days in a row
Oct 2, 2026 β€” HAO ends flat (+0.0%) to $2.70, 7 down days in a row

HAO latest news & SEC filings

Every SEC filing by or about HAO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 30, 2026 Β· Form 20-F β€” Annual report from a foreign company (20-F)

Annual report from a foreign company (20-F)

Fiscal year ended Jun 30, 2026:

Source: SEC EDGAR filing 0001213900-26-105242

Jul 13, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-077575

Jul 13, 2026 Β· Form 424B5 β€” Prospectus supplement

Prospectus supplement β€” the company is selling securities off a shelf registration

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-077423

Jul 6, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-075499

Jun 24, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-071499

Things to know before you trade HAO

HAO market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 20262.272.272.102.1931.50K
Oct 14, 20262.242.242.102.1663.20K
Oct 13, 20262.392.392.272.2734.60K
Oct 12, 20262.342.542.312.4442.50K
Oct 9, 20262.462.462.302.4052.10K
Oct 8, 20262.532.582.452.5013.80K
Oct 7, 20262.372.642.372.6038.30K
Oct 6, 20262.622.632.382.4242.10K
Oct 5, 20262.612.702.532.6344.20K
Oct 2, 20262.672.772.622.7024.20K
Oct 1, 20262.672.782.672.7018.30K
Sep 30, 20262.712.852.712.7325.50K
Sep 29, 20262.792.792.652.7528.70K
Sep 28, 20262.912.912.752.8931.90K
Sep 25, 20262.902.902.802.9052.80K
Sep 24, 20263.033.122.842.9782.70K
Sep 23, 20263.353.352.753.161.25M
Sep 22, 20262.792.852.772.85323.10K
Sep 21, 20262.802.882.732.7516.50K
Sep 18, 20262.952.952.762.8720.50K

About Haoxi Health Technology

Haoxi Health Technology (HAO) is listed on the Nasdaq and classified by the SEC under β€œServices-Advertising Agencies”. Its business address is in BEIJING. State of incorporation: Cayman Islands. Fiscal year ends June 30. SEC CIK 1954594.

HAO board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Zhen FanCEO & ChairmanMay 20, 2026
Chuanjie HuDirectorApr 2, 2026
Jia LiuDirectorMar 19, 2026
Changmao SuDirectorApr 2, 2026
Lei Lx XuChief Operating OfficerApr 6, 2026

Executive officers

NameTitleLatest filing
Zhen FanCEO & ChairmanMay 20, 2026
Dongxue LiChief Financial OfficerApr 2, 2026
Lei Lx XuChief Operating OfficerApr 6, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
May 19, 2026Zhen FanBuy40,000,000$0.02

HAO financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

HAO earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Services-Advertising Agencies

Omnicom (OMC)Groupon (GRPN)Stagwell (STGW)Wpp (WPP)Criteo (CRTO)Vs Media (VSME)Stran (SWAG)Tjgc (TJGC)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on HAO

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.